Why Moderna’s cancer vaccine is a breakthrough for mRNA

The Straits Times reports that Moderna's cancer vaccine is a breakthrough for mRNA technology. It's the first time an mRNA-based cancer vaccine has succeeded in a large-scale study. Moderna, the biotech company known for its COVID-19 vaccine, is behind the messenger RNA approach.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton